We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

ALIFAX DIAG/SRE

Develops automated diagnostic instruments for ESR testing and Bacterial Culture read more Featured Products: More products

Download Mobile App





Alifax S.r.l. Highlights First Automated System for Bacterial Culture and Susceptibility Testing

By LabMedica International staff writers
Posted on 20 Nov 2019
Alifax S.r.l. More...
(Padua, Italy) highlighted its innovative diagnostic instrumentation portfolio at the 2019 edition of MEDICA, the world's largest trade fair for medical technology, held from 18 to 21 November in Düsseldorf, Germany.

Alifax is present in the laboratory diagnostic market and develops instruments and kits with a focus of the total laboratory automation requirements providing fast and reliable results, method standardization, sample traceability and easy-to-use protocols. Alifax’s innovative diagnostic products include Test1 and Roller 20 for the analysis of ESR in 20 seconds, Alfred AST sepsis analyzer for RAPID Bacterial Culture, antimicrobial susceptibility testing and MDRO screening and ALIBOX, a smart patented device designed to improve and certify bio-material transportation by active temperature control and multiple-parameter monitoring as temperature and location on a cloud-based service. It has also introduced the new I-dOne, a reagent free ATR-FTIR based system for microorganism identification in only one minute from isolated colony without sample preparation or pre-treatment.

At MEDICA 2019, Alifax highlighted its real walk-away automated streaking system for rapid bacterial culture and plate streaking of liquid samples that is composed of two units: Alfred 60AST and Sidecar. Alfred 60AST is the first fully automated system able to perform bacterial culture, RAA and susceptibility testing by automating the entire process of sample inoculation, reading and result transmission. Using patented technology based on light scattering, it is able to detect the presence of bacteria and their drug resistance in a few hours with high sensitivity and specificity. Alfred 60AST monitors the growth phases of bacteria from the inoculum step into specific culture broths, providing real time growth curves and quantitative bacterial count results in CFU/ml. Broth turbidity level is detected by the McFarland Monitor and as the sample reaches the 0.5 McFarland, it is buffered into the refrigerated area and then tested with a customized antibiotic panel. The Sidecar streaking unit stocks 240 Petri dishes and up to 12 different media. The streaked dishes are incubated on board at 37°C for the requested analysis time.

Alifax also highlighted HB&L, the first analyzer able to perform bacterial culture, RAA test and susceptibility testing on samples such as urine, sterile or non sterile fluids and other biological samples. Using patented technology based on light scattering, it can detect the presence of bacteria and their drug resistance in a few hours with high sensitivity and specificity. HB&L also monitors the growth phases of bacteria from the inoculum step into specific culture broths providing real time growth curves and quantitative bacterial count results in CFU/ml. Broth turbidity level is detected by McFarland Monitor and, as the sample reaches the 0.5 McFarland, a visual and audible alert advises that the bacterial culture is ready to be tested for a customized antibiotic panel without awaiting the end of the analysis and avoiding further dilution steps. HB&L’s software flexibility allows different tests to be performed simultaneously, with each reading unit position being independent from the others and can be set according to sample type, incubation time, test profile, analytical protocol and cut-off.

Related Links:
Alifax S.r.l.


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.